Memory loss isn’t “normal”: closing Australia’s Alzheimer’s diagnosis gap

Australia is entering a new era of ageing. By 2026, life expectancy is projected to reach 84.3 years – among the highest worldwide. But longevity comes with urgency: dementia, including Alzheimer’s disease, is now Australia’s leading cause of death, accounting for 9.4% of all fatalities. More than 446,000 Australians are currently living with dementia –…

Read More

Visualising complex science for maximum impact

In healthcare communications, some of the most important messages are decided before a single word is read. Scientific evidence, regulatory nuance, and patient impact demand careful explanation. Yet audiences scan, interpret, and react visually first. Visual communication acts as a shortcut to clarity, allowing complex ideas to be understood quickly and intuitively. Unlike written language,…

Read More

Rare but rarely recognised: Accelerating diagnosis, access, & innovation for rare diseases in Australia & APAC

Two million Australians are living with a rare disease, yet diagnosis can take five-to-seven years. Across APAC, fragmented systems, limited awareness, and uneven access to therapies create both challenges and opportunities for pharma, biotech, and medtech innovators. This Rare Disease Day, it’s time to move from awareness to action, shortening diagnostic journeys, improving access, and…

Read More

Shaping your brand in an AI-driven world

AI shapes perception – ensure it shapes yours In 2026, generative artificial intelligence (GenAI) AI is increasingly shaping your brand before anyone sees it. Large language models (LLMs) such as ChatGPT and Gemini are becoming the first stop for patients, clinicians, policymakers, and journalists. In healthcare, this means your story is summarised, interpreted, and presented…

Read More